Epidemiology and determinants of facial telangiectasia: a cross‐sectional study
Background Telangiectasia or red veins are one of the prominent features of facial skin ageing. To date, there are few studies investigating the determinants of telangiectasia. Objectives We investigated lifestyle and physiological factors associated with facial telangiectasia in a large prospective...
Saved in:
Published in: | Journal of the European Academy of Dermatology and Venereology Vol. 34; no. 4; pp. 821 - 826 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
01-04-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
Telangiectasia or red veins are one of the prominent features of facial skin ageing. To date, there are few studies investigating the determinants of telangiectasia.
Objectives
We investigated lifestyle and physiological factors associated with facial telangiectasia in a large prospective Dutch cohort study.
Methods
Telangiectasia was quantified digitally from standardized facial photographs of 2842 North European participants (56.8% female, median age 66.9) from the Rotterdam Study, collected in 2010–2013. Effect estimates from multivariable linear regressions are presented as the percentage difference in the mean value of telangiectasia area per unit increase of a determinant (%Δ) with corresponding 95% CI.
Results
Significant determinants were older age [1.7%Δ per year (95% CI 1.4, 2.0)], female sex [18.3%Δ (95% CI 13.2, 23.6)], smoking [current versus never 38.4%Δ (95% CI 30.3, 47.0); former versus never 11.6%Δ (95% CI 6.6, 16.9)], a high susceptibility to sunburn [10.2%Δ (95% CI 5.4, 15.3)] and light skin colour [pale versus white‐to‐olive 31.4%Δ (95% CI 19.7, 44.1]; white vs. white‐to‐olive 9.2%Δ (95% CI 2.8, 16.0)].
Conclusions
In this large cohort study, we confirmed known and described new determinants of facial telangiectasia. |
---|---|
Bibliography: | Conflicts of interest Although no products were tested, it is possible these results could be used to promote products and services that lead to a financial gain for Unilever. Funding sources This study is funded by Unilever. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. Authors SM and MAH are supported by Unilever, and author DAG is Unilever employee. The SALIA study was funded by the Deutsche Forschungsgemeinschaft (DFG; HE‐4510/2‐1, KR 1938/3‐1, LU 691/4‐1), by the Ministry of the Environment of the state North Rhine‐Westphalia (Düsseldorf, Germany), by the Federal Ministry of the Environment (Berlin, Germany) and by the DGUV (German statutory accident assurance) VT 266.1. |
ISSN: | 0926-9959 1468-3083 |
DOI: | 10.1111/jdv.15996 |